Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ASH 2014 /
ASH 2014: Highlights in CLL from ASH 2014

6th - 9th Dec 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 08.12.14
Views: 3599
Rating:

Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger

Prof Hillmen (St James’ University Hospital, Leeds, UK) chairs a discussion with Prof Wendtner (University of Cologne, Cologne, Germany), and Prof Ulrich Jäger (Medical University of Vienna, Austria) for ecancertv about the data and opinions arising from ASH 2014 on the treatment of chronic lymphocytic leukaemia (CLL).

This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).

 

 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation